基本信息
views: 20
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Cappellini is being recognized for her research in novel therapeutic challenges for thalassemias and sickle cell disease, including gene therapy and other pharmacologic treatments. These new treatments could significantly change the survival and quality of life of people suffering from these diseases. She has been involved in translational and clinical research focused on thalassemia for nearly 4 decades. Through the advent of techniques of molecular biology in the 1980s, Dr. Cappellini characterized the genotypes and phenotypes of beta-thalassemia major, beta-thalassemia intermedia, alpha-thalassemia, and rare combinations of thalassemias that informed researchers’ understanding of the natural history of these disorders and allowed for molecular-based genetic counseling and prenatal diagnosis.
Research Interests
Papers共 948 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Blood reviews (2024): 101165-101165
Achille Iolascon, Immacolata Andolfo, Roberta Russo,Mayka Sanchez, Fabiana Busti, Dorine Swinkels, Patricia Aguilar Martinez,Rayan Bou-Fakhredin,Martina U Muckenthaler,Sule Unal,Graça Porto,Tomas Ganz,
HemaSphereno. 7 (2024): e108-e108
Transplantation and Cellular Therapyno. 2 (2024): S236
The Lancet Haematologyno. 6 (2024): e403-e403
Annals of Hematologyno. 3 (2024): 1025-1026
Science Translational Medicineno. 698 (2023)
Alì Taher,Vip Viprakasit,Maria Domenica Cappellini,Antonio Piga,John B. Porter,Thomas D. Coates,Khaled M. Musallam,Gian Luca Forni,Jeevan K. Shetty, Marija Bosilkovska Weisskopf,Richard Wei,Wen‐Ling Kuo,
HemaSphereno. S3 (2023): e45673ef-e45673ef
Load More
Author Statistics
#Papers: 939
#Citation: 28908
H-Index: 80
G-Index: 144
Sociability: 8
Diversity: 4
Activity: 124
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn